SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 100 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,862,152 | -46.5% | 472,600 | -22.9% | 0.65% | -37.4% |
| Q2 2023 | $12,821,718 | -0.9% | 612,600 | 0.0% | 1.04% | -3.4% |
| Q1 2023 | $12,938,112 | -17.0% | 612,600 | 0.0% | 1.07% | -19.3% |
| Q4 2022 | $15,590,670 | +5.9% | 612,600 | 0.0% | 1.33% | +14.2% |
| Q3 2022 | $14,721,000 | +24.9% | 612,600 | 0.0% | 1.16% | +13.3% |
| Q2 2022 | $11,786,000 | +10.7% | 612,600 | 0.0% | 1.03% | +24.8% |
| Q1 2022 | $10,647,000 | -18.8% | 612,600 | +2.3% | 0.82% | -1.8% |
| Q4 2021 | $13,110,000 | +54.2% | 598,900 | +34.6% | 0.84% | +63.4% |
| Q3 2021 | $8,502,000 | +23.4% | 444,900 | +10.9% | 0.51% | +35.0% |
| Q2 2021 | $6,887,000 | +16.6% | 401,100 | +51.8% | 0.38% | +12.8% |
| Q1 2021 | $5,908,000 | +0.5% | 264,200 | 0.0% | 0.34% | +9.4% |
| Q4 2020 | $5,876,000 | +100.7% | 264,200 | +33.2% | 0.31% | +91.3% |
| Q3 2020 | $2,928,000 | +54.7% | 198,400 | +55.4% | 0.16% | +41.2% |
| Q2 2020 | $1,893,000 | +161.1% | 127,700 | +93.2% | 0.11% | +86.9% |
| Q1 2020 | $725,000 | – | 66,100 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,025,000 | $21,648,000 | 10.42% |
| Foresite Capital Management IV, LLC | 875,000 | $18,480,000 | 9.59% |
| Kynam Capital Management, LP | 3,205,986 | $67,710,424 | 8.74% |
| Frazier Life Sciences Management, L.P. | 3,708,838 | $78,330,659 | 5.67% |
| ACUTA CAPITAL PARTNERS, LLC | 330,000 | $6,969,600 | 5.13% |
| Paradigm Biocapital Advisors LP | 2,274,512 | $48,037,693 | 4.55% |
| Eversept Partners, LP | 2,209,057 | $46,655,284 | 3.25% |
| DAFNA Capital Management LLC | 447,073 | $9,442,182 | 2.83% |
| COMMODORE CAPITAL LP | 853,884 | $18,034,030 | 2.75% |
| Avidity Partners Management LP | 3,865,300 | $81,635,136 | 2.71% |